Peptide CDMO Service
ScinoPharm accumulate >20 years solid experience in peptide synthesis. ScinoPharm offers a comprehensive technology platform and a highly skilled team capable to deliver tailored synthesis strategies for peptides with diverse properties and requirements. Solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), and hybrid synthesis approaches are feasible for synthesis strategy design.
We have successfully supported clients from early stage development to worldwide commercial supply including US and Europe. This track record highlights our competitive strengths in quality, regulatory compliance, and supply reliability.
ScinoPharm is your trusted CDMO partner for peptide development and manufacturing.
We have successfully supported clients from early stage development to worldwide commercial supply including US and Europe. This track record highlights our competitive strengths in quality, regulatory compliance, and supply reliability.
ScinoPharm is your trusted CDMO partner for peptide development and manufacturing.
| CDMO Service Scope |
|---|
| Process development, optimization, and transfer |
| Analytical method development, optimization, and transfer |
|
Process parameter characterization (CPP, NOR, POR) |
|
Analytical Method validation |
|
Pre-clinical material, Toxicology batch API manufacturing |
|
Clinical used cGMP grade API manufacturing |
|
Commercial supply cGMP grade API manufacturing |
|
mg-g lab use peptide synthesis service |
| Compliant with cGMP, PICS/GMP |
